Arteris' stock (NASDAQ: AIP) is on the move pre-market, up 57% at $14.84 as a newly announced partnership with AMD to provide its FlexGen interconnect IP for AMD's next-generation AI chiplet designs causes a wave of excitement.
The deal is being hailed as a major validation of Arteris' technology, sending shares soaring and sparking speculation about significant future upside.
The partnership with AMD involves licensing Arteris' FlexGen network-on-chip (NoC) interconnect IP for AMD's upcoming AI chiplet designs. The FlexGen technology is designed to optimize data transport within these chiplets, which are crucial for applications ranging from data centers to edge devices.
This collaboration underscores the increasing complexity of modern System-on-Chip (SoC) and chiplet architectures, requiring advanced interconnect solutions to meet the demands of cutting-edge electronic systems.
The market's reaction to the news has been overwhelmingly positive, with many investors drawing comparisons to other companies that experienced huge growth after securing similar high-profile partnerships. Some analysts believe that this deal could significantly boost Arteris' revenue and market share in the long term.
Arteris is also scheduled to release its Q2 financial results today. Last quarter, the company reported $17 million in revenue and a loss of $0.09 per share, beating revenue expectations by $602,000 and meeting earnings estimates. Markets are looking for a loss of $0.10 this time around, with revenue expected at $16.35M.
Searching for the Perfect Broker?
Discover our top-recommended brokers for trading or investing in financial markets. Dive in and test their capabilities with complimentary demo accounts today!
- eToro Wide range of instruments available to trade – Read our Review
- Vantage High levels of account and deposit protection – Read our Review
- BlackBull 26,000+ Shares, Options, ETFs, Bonds, and other underlying assets – Read our Review
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY